Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas

PloS One
Lindsey OudijkJudith Favier

Abstract

Pheochromocytomas (PCCs) are neuroendocrine tumors arising from chromaffin cells of the adrenal medulla. Related tumors that arise from the paraganglia outside the adrenal medulla are called paragangliomas (PGLs). PCC/PGLs are usually benign, but approximately 17% of these tumors are malignant, as defined by the development of metastases. Currently, there are no generally accepted markers for identifying a primary PCC or PGL as malignant. In 2002, Favier et al. described the use of vascular architecture for the distinction between benign and malignant primary PCC/PGLs. The aim of this study was to validate the use of vascular pattern analysis as a test for malignancy in a large series of primary PCC/PGLs. Six independent observers scored a series of 184 genetically well-characterized PCCs and PGLs for the CD34 immunolabeled vascular pattern and these findings were correlated to the clinical outcome. Tumors were scored as malignant if an irregular vascular pattern was observed, including vascular arcs, parallels and networks, while tumors with a regular pattern of short straight capillaries were scored as benign. Mean sensitivity and specificity of vascular architecture, as a predictor of malignancy was 59.7% and 72.9%, respecti...Continue Reading

References

Mar 17, 2001·BJU International·H OhjiT Nakada
Oct 9, 2002·The American Journal of Pathology·Judith FavierJean-Marie Gasc
Mar 18, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·E Edström ElderM Bäckdahl
Apr 7, 2004·Endocrine Pathology·Patrick P G M RooijensErwin van der Harst
May 29, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Christian AugustHorst Buerger
Aug 17, 2005·PLoS Genetics·Patricia L M DahiaCharles D Stiles
Aug 23, 2005·Lancet·Jacques W M LendersKarel Pacak
Jan 15, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Fabio de SouzaMarco Antonio de Mattos
Jan 16, 2009·The American Journal of Surgical Pathology·David WuVânia Nosé
Mar 23, 2011·The Journal of Urology·Feng FengZhouJun Shen
Nov 2, 2011·Endocrine-related Cancer·Jenny WelanderOliver Gimm
Feb 14, 2012·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·A-P Gimenez-RoqueploM Robledo
Oct 24, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Felipe R LorenzoJosef T Prchal
May 4, 2013·The Journal of Clinical Endocrinology and Metabolism·Joakim CronaPeyman Björklund
May 28, 2013·Cancer Cell·Eric LetouzéJudith Favier
Jan 21, 2014·Nature Reviews. Cancer·Patricia L M Dahia
Feb 14, 2014·Endocrine-related Cancer·Noriko KimuraMitsuhide Naruse
Jun 4, 2014·The Journal of Clinical Endocrinology and Metabolism·Jacques W M LendersWilliam F Young

❮ Previous
Next ❯

Citations

Jul 3, 2015·Endocrine-related Cancer·Arthur S Tischler, Ronald R deKrijger
Dec 15, 2017·Histopathology·John TurchiniAnthony J Gill
Jul 6, 2016·Der Pathologe·W SaegerP Komminoth
Sep 25, 2017·The Journal of Clinical Endocrinology and Metabolism·Lucie EvenepoelEsther Korpershoek
May 6, 2019·Annales d'endocrinologie·Judith GoncalvesLuis Jaime Castro-Vega

❮ Previous
Next ❯

Software Mentioned

- it
Analyse
it

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.